At close: 1:35:56 PM GMT+1
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Operating Cash Flow
-98,107.0000
-114,575.0000
-94,640.0000
-52,126.0000
-34,409.0000
Investing Cash Flow
-129.0000
-585.0000
-2,779.0000
-3,398.0000
-3,560.0000
Financing Cash Flow
113,707.0000
79,502.0000
122,009.0000
-136.0000
142,661.0000
End Cash Position
62,403.0000
79,407.0000
114,327.0000
89,793.0000
145,364.0000
Capital Expenditure
-7,035.0000
-146.0000
-2,779.0000
-3,398.0000
-3,560.0000
Issuance of Capital Stock
134,958.0000
99,121.0000
150,090.0000
1,201.0000
143,949.0000
Repayment of Debt
-940.0000
--
--
--
--
Free Cash Flow
-98,253.0000
-114,721.0000
-97,419.0000
-55,524.0000
-37,969.0000
4/30/2021 - 3/29/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EGTX.ST Egetis Therapeutics AB (publ)
6.53
-0.91%
ALZCUR.ST AlzeCure Pharma AB (publ)
1.2150
-3.95%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4490
-3.02%
BSLNz.XC
ACTI.ST Active Biotech AB (publ)
0.1106
-1.07%
IMMU.ST Mendus AB (publ)
8.85
+4.55%
ULTI.OL Ultimovacs ASA
2.4500
-3.92%
BINV.ST BioInvent International AB (publ)
38.80
-0.26%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
21.40
+2.88%
ATORX.ST Alligator Bioscience AB (publ)
0.2600
-2.44%